Full text
Earnings transcript
Read the complete earnings call transcript.
ATR
AptarGroup, Inc.
$142.92
-3.94
(-2.68%)
| Exchange: | NYSE |
| Market Cap: | 9.06B |
| Shares Outstanding: | 65.74M |
Delayed data
About The Company
| Sector: | HealthcareView sector performance | |||||
| Industry: | Medical – Instruments & SuppliesView industry performance | |||||
| CEO: | Gael Touya | |||||
| Full Time Employees: | 14000 | |||||
| Address: |
| |||||
| Website: | https://www.aptar.com |
AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.
Click to read more…
Revenue Segmentation
Revenue by type
Revenue by region
ATR full analysis
Welcome to MARKETSNAP’s SWOT analysis for AptarGroup, or ATR as it’s known on the ticker. If you’re not familiar with AptarGroup, let me give you the quick rundown. They’re a global leader in the packaging and dispensing solutions space, operating primarily in the consumer goods and pharmaceutical sectors. Think innovative drug delivery systems, beauty product packaging, and food and beverage closures. They’ve carved out a solid niche in an industry that’s all about precision and reliability, and they’ve got a…
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 3,487,450 | 3,582,890 | 3,777,181 |
| Gross Profit | 1,263,399 | 1,355,509 | 1,117,372 |
| EBITDA | 663,836 | 777,447 | 831,478 |
| Operating Income | 404,019 | 496,497 | 512,335 |
| Net Income | 284,487 | 374,541 | 392,789 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total Assets | 4,451,890 | 4,432,278 | 5,252,719 |
| Total Liabilities | 2,130,592 | 1,946,354 | 2,540,494 |
| Total Stockholders Equity | 2,306,824 | 2,471,888 | 2,668,096 |
| Total Debt | 1,184,675 | 1,076,067 | 1,139,433 |
| Cash and Cash Equivalents | 223,643 | 223,844 | 402,424 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating Cash Flow | 575,239 | 643,413 | 569,999 |
| Capital Expenditure | -318,403 | -294,190 | -270,419 |
| Free Cash Flow | 256,836 | 349,223 | 299,580 |
| Net Income | 284,176 | 374,178 | 392,789 |
| Net Change in Cash | 81,411 | 201 | 178,080 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2030 | Research Access | Research Access | Research Access | Research Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 4,898,402.756 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (High) | 5,057,253.925 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (Avg) | 4,977,300 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Low) | 1,152,159.115 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (High) | 1,183,786.642 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Avg) | 1,167,867.898 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Low) | 571,812.565 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (High) | 596,035.742 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Avg) | 583,843.750 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Low) | 775,638.998 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (High) | 800,792.332 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Avg) | 788,132.004 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Avg) | 8.750 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (High) | 8.930 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Low) | 8.570 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated Revenue) | 2 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated EPS) | 1 | Research Access | Research Access | Research Access | Research Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
Strengths (preview)
- Robust Financial Performance: Aptar reported strong Q2 2025 results, surpassing the high end of guidance, as highlighted in the earnings call transcript. Key financial metrics such as revenue, operating income, and net income reflect consistent growth, supported by operational efficiency and innovation-driven product offerings.
- Positive Free Cash Flow: Cash flow statements indicate sustained free cash flow generation, with a favorable free cash flow yield (TTM) as per key metrics. This provides financial flexibility for reinvestment in growth initiatives and debt management.
- Innovation and Market Position: The earnings call emphasizes Aptar’s focus on innovation, positioning the company as a leader in its industry (as per company profile and description). This is further supported by strong gross and net profit margins (TTM), indicating competitive pricing power and operational excellence.
Log in with Research Access for Weaknesses, Opportunities, Threats, and the complete SWOT.
At what price to buy it? -
Intrinsic Value Calculator
Based on current fundamentals and analyst forecasts, MarketSnap estimates ATR intrinsic value between $105.13 – $121.36 per share. This depends on revenue growth, margins, and discount rate.
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
Common questions about ATR valuation
Is AptarGroup, Inc. (ATR) overvalued or undervalued right now?
MarketSnap estimates intrinsic value for AptarGroup, Inc. (ATR) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is ATR a buy, hold, or sell for long-term investors?
MarketSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether ATR trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is ATR’s P/E ratio?
You can see ATR’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for ATR?
MarketSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MarketSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is ATR a good long-term investment?
Whether ATR fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MarketSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
ATR
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
-2.68
Trading Metrics:
| Open: | 147.17 | Previous Close: | 146.86 | |
| Day Low: | 142.02 | Day High: | 148.59 | |
| Year Low: | 110.95 | Year High: | 148.59 | |
| Price Avg 50: | 126.44 | Price Avg 200: | 127.24 | |
| Volume: | 340732 | Average Volume: | 468017 |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's free
